Tada, T., Norton, T. D., Leibowitz, R., & Landau, N. R. (2022). Directly injected lentiviral vector–based T cell vaccine protects mice against acute and chronic viral infection. American Society for Clinical investigation.
Chicago Style (17th ed.) CitationTada, Takuya, Thomas D. Norton, Rebecca Leibowitz, and Nathaniel R. Landau. Directly Injected Lentiviral Vector–based T Cell Vaccine Protects Mice Against Acute and Chronic Viral Infection. American Society for Clinical investigation, 2022.
MLA (9th ed.) CitationTada, Takuya, et al. Directly Injected Lentiviral Vector–based T Cell Vaccine Protects Mice Against Acute and Chronic Viral Infection. American Society for Clinical investigation, 2022.
Warning: These citations may not always be 100% accurate.